KCTD11 and lung cancer: The results of this study indicate that the human potassium channel tetramer protein KCTD11 can bind to β‐catenin through its BTB domain in NSCLC cells, inhibit the Wnt pathway, increase Hippo pathway activity, and inhibit the proliferation and migration of lung cancer cells.